Fernö, M <br/><br/>
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  May 1996 
 - 793-801 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/0959-8049(95)00652-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cytosol--enzymology<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunoassay--methods<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Multivariate Analysis<br/>Prognosis<br/>Prospective Studies<br/>Tamoxifen--therapeutic use<br/>Urokinase-Type Plasminogen Activator--analysis